Benefits of intensive insulin therapy on neuromuscular complications in routine daily critical care practice: a retrospective study
Open Access
- 24 January 2009
- journal article
- research article
- Published by Springer Nature in Critical Care
- Vol. 13 (1) , R5
Abstract
Introduction: Intensive insulin therapy (IIT) reduced the incidence of critical illness polyneuropathy and/or myopathy (CIP/CIM) and the need for prolonged mechanical ventilation (MV ≥ 14 days) in two randomised controlled trials (RCTs) on the effect of IIT in a surgical intensive care unit (SICU) and medical intensive care unit (MICU). In the present study, we investigated whether these effects are also present in daily clinical practice when IIT is implemented outside of a study protocol. Methods: We retrospectively studied electrophysiological data from patients in the SICU and MICU, performed because of clinical weakness and/or weaning failure, before and after routine implementation of IIT. CIP/CIM was diagnosed by abundant spontaneous electrical activity on electromyography. Baseline and outcome variables were compared using Student's t-test, Chi-squared or Mann-Whitney U-test when appropriate. The effect of implementing IIT on CIP/CIM and prolonged MV was assessed using univariate analysis and multivariate logistic regression analysis (MVLR), correcting for baseline and ICU risk factors. Results: IIT significantly lowered mean (± standard deviation) blood glucose levels (from 144 ± 20 to 107 ± 10 mg/dl, p < 0.0001) and significantly reduced the diagnosis of CIP/CIM in the screened long-stay patients (125/168 (74.4%) to 220/452 (48.7%), p < 0.0001). MVLR identified implementing IIT as an independent protective factor (p < 0.0001, odds ratio (OR): 0.25 (95% confidence interval (CI): 0.14 to 0.43)). MVLR confirmed the independent protective effect of IIT on prolonged MV (p = 0.002, OR:0.40 (95% CI: 0.22–0.72)). This effect was statistically only partially explained by the reduction in CIP/CIM. Conclusions: Implementing IIT in routine daily practice in critically ill patients evoked a similar beneficial effect on neuromuscular function as that observed in two RCTs. IIT significantly improved glycaemic control and significantly and independently reduced the electrophysiological incidence of CIP/CIM. This reduction partially explained the beneficial effect of IIT on prolonged MV.Keywords
This publication has 20 references indexed in Scilit:
- Impact of Intensive Insulin Therapy on Neuromuscular Complications and Ventilator Dependency in the Medical Intensive Care UnitAmerican Journal of Respiratory and Critical Care Medicine, 2007
- Risk factors for critical illness polyneuromyopathyJournal of Neurology, 2005
- Effect of critical illness polyneuropathy on the withdrawal from mechanical ventilation and the length of stay in septic patients*Critical Care Medicine, 2005
- Does ICU-acquired paresis lengthen weaning from mechanical ventilation?Intensive Care Medicine, 2004
- Critical illness polyneuropathy: risk factors and clinical consequences. A cohort study in septic patientsIntensive Care Medicine, 2001
- Critical illness myopathyMuscle & Nerve, 2000
- Critical illness polyneuropathy and myopathy (CIPNM): evidence for local immune activation by cytokine-expression in the muscle tissueJournal of Neuroimmunology, 2000
- Critical illness myopathy and neuropathyThe Lancet, 1996
- The Role of Polyneuropathy in Motor Convalescence After Prolonged Mechanical VentilationJAMA, 1995
- Critically ill polyneuropathy: electrophysiological studies and differentiation from Guillain-Barre syndrome.Journal of Neurology, Neurosurgery & Psychiatry, 1986